ClinConnect ClinConnect Logo
Search / Trial NCT06146608

Heme and Non-heme Iron Intakes, Gut Microbiota, and Influence on Host Iron Absorption

Launched by CORNELL UNIVERSITY · Nov 21, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The FeMicrobiome study is a clinical trial that aims to understand how our gut bacteria (the microbiome) interact with the iron we get from our food. Researchers want to see if the type of iron we eat—heme iron (found in animal products) and non-heme iron (found in plant foods)—affects how our body absorbs iron. This study is important because it could help explain why some people absorb iron better than others, which is particularly relevant for conditions like anemia (low iron) and iron overload (too much iron).

To participate in this study, you would need to be a healthy adult between the ages of 18 and 40, not currently smoking, and not taking any vitamin or mineral supplements. Women must be premenopausal and not pregnant or breastfeeding. If you qualify and choose to join, you can expect to provide dietary information and possibly undergo tests to assess your iron absorption. This research could lead to better dietary recommendations for people facing iron-related health issues in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Healthy adults
  • Age between 18- 40y
  • Non-smoking
  • Not currently taking vitamin, mineral, prebiotic, and probiotic supplements.
  • Females: premenopausal and not pregnant or lactating
  • No preexisting medical complications (such as eating disorders, hemoglobinopathies, malabsorption diseases, steroid use, substance abuse history, or taking medications known to influence iron homeostasis)
  • Body mass index (BMI) between 18 - 27 kg/m2.
  • Exclusion Criteria:
  • BMI \<18 or \> 27 kg/m2,
  • Age \<18 y or \> 40y,
  • Smoking
  • Pregnancy, lactating
  • Have gastrointestinal disorders/malabsorption diseases/hemoglobinopathies/dietary restrictions/steroid use/ medication use of medications known to impact iron status, iron utilization or inflammatory status
  • Currently take vitamin, mineral, prebiotic, and probiotic supplements.
  • Recently received antibiotic treatment

About Cornell University

Cornell University is a prestigious Ivy League institution renowned for its commitment to academic excellence and innovative research. As a clinical trial sponsor, Cornell leverages its interdisciplinary expertise and state-of-the-art facilities to advance medical knowledge and improve patient outcomes. The university fosters collaboration among leading researchers, clinicians, and students, aiming to translate scientific discoveries into effective therapies. Cornell's rigorous adherence to ethical standards and regulatory compliance ensures the integrity and safety of its clinical trials, contributing to the advancement of healthcare and the well-being of communities.

Locations

Ithaca, New York, United States

Patients applied

0 patients applied

Trial Officials

KIMBERLY ORA OBRIEN, PhD

Principal Investigator

Cornell University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported